EUDA Health (EUDA) Fundamental Analysis: Revenue, Earnings & Valuation

0.65 / 10

Underperform

EUDA Health's fundamental health is concerning: the financial score is only 0.7 out of 10. Critical red flags include a negative Return on Equity at -28.4%, a high accounts receivable turnover ratio of 10.67—implying potential collection issues—and a shareholders' equity decline of -45.3% year-over-year. These metrics place the company in the lowest performance quartiles historically, with back-tests showing negative monthly returns. The interest coverage ratio of 27.6 offers some cushion, but it is insufficient to offset other deteriorating factors.

Analysis Checks(2/9)

Annualized return on equity (%)

Value-56.80

Score0/3

Weight17.38%

1M Return-8.10%

Accounts receivable turnover ratio

Value10.67

Score0/3

Weight15.49%

1M Return-5.37%

Quick ratio

Value0.21

Score0/3

Weight10.24%

1M Return-3.75%

Shareholders’ equity attributable to parent company (growth rate compared to beginning of year %)

Value-45.30

Score0/3

Weight19.86%

1M Return-9.17%

Total profit / EBIT (%)

Value103.76

Score1/3

Weight3.71%

1M Return-1.21%

Long-term debt to working capital ratio (%)

Value7.24

Score0/3

Weight19.01%

1M Return-8.29%

Interest coverage ratio (EBIT / Interest expense) (%)

Value27.60

Score2/3

Weight6.78%

1M Return-2.49%

Operating revenue (YoY growth rate %)

Value60.23

Score3/3

Weight-9.84%

1M Return3.00%

ROE (%)

Value-28.40

Score0/3

Weight17.38%

1M Return-8.10%

Is EUDA fundamentally strong?

EUDA scores 0.65/10 on fundamentals and holds a Premium valuation at present. Backed by its 0.00% ROE, 4.65% net margin, 154.66 P/E ratio, -11.07 P/B ratio, and 114.29% earnings growth, these metrics solidify its Underperform investment rating.